<DOC>
	<DOCNO>NCT00925899</DOCNO>
	<brief_summary>BACKGROUND : Patients advance cancer often suffer fatigue symptom problem insomnia , appetite loss pain . Problems may great consequence quality life . Several study suggest supplement hormone melatonin ( MLT ) may beneficial effect symptoms/problems . This need investigation . AIM : To investigate supplement melatonin effect ) fatigue ( primary outcome trial ) , b ) symptom insomnia , appetite loss , depression pain , c ) overall quality life . METHODS AND PATIENTS : The trial take place Department Palliative Medicine , Bispebjerg Hospital , 50 patient participate . The participant 18 year , advance cancer , suffer quite bit much fatigue . The study consist two part . In part I investigate melatonin well effect placebo outcome mention . This part consecutive , prospective , double blind , randomize ( MLT vs. placebo ) , cross-over study patient serve control . In part II effect melatonin time investigate . Part II consecutive , prospective , open-label study . The outcome assess weekly questionnaire ( MFI-20 EORTC QLQ-C15PAL ) daily diary question . Melatonin use several study , general conclusion safe substance adverse drug reaction . PERSPECTIVES : If melatonin potential alleviate fatigue symptom patient advance cancer enhance quality life patient , benefit many future patient . Trials important nationally internationally develop evidence-based palliative medicine .</brief_summary>
	<brief_title>Melatonin Fatigue Other Symptoms Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Answered `` quite bit '' `` much '' question `` tire ? '' ( EORTC QLQC15PAL ) Cancer palliative phase Written inform consent Age 18 year Not capable understand judge information , fill questionnaire Untreated anemia ( Hb &lt; = 6,0 mmol/L ) Untreated hypocalcaemia Systolic blood pressure &lt; 100 In treatment coumadin Receiving unstable dos methylphenidate , corticosteroid sleep medicine past two week TSH &lt; 0.50 &gt; 5.50 mcL/mL Pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Melatonin</keyword>
	<keyword>Palliative care</keyword>
	<keyword>Advanced cancer</keyword>
	<keyword>Symptoms</keyword>
	<keyword>Quality life</keyword>
	<keyword>Randomized control trial</keyword>
</DOC>